The variations in the MUC5AC glycoforms used, study populations (e.g., BTC vs. ICC-only vs. ECC-only vs. CCA vs. GBC) analyzed, other study methods utilized, and outcomes reported among the studies makes it difficult to draw concrete conclusions. Here, MUC5AC is linked to intrahepatic cholangiocarcinoma.